Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
120 participants
INTERVENTIONAL
2020-11-04
2024-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optimizing Outcomes for Young Autistic Children
NCT05926687
Improving Academic and Social Functioning in Middle-Schoolers With Autism
NCT06705907
Study of a Paraprofessional-Delivered After-School Social Intervention for Autistic Children
NCT05542602
Social and Communication Outcomes for Young Children With Autism
NCT00953095
Evaluating Stress Management Strategies Within the School Readiness Parenting Program
NCT06626750
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Objectives: The purpose of this project is to test the efficacy of the Modular Approach for Autism Programs in Schools (MAAPS). The Modular Approach for Autism Programs in Schools (MAAPS) is an individualized, comprehensive modular intervention system integrating evidence-based strategies to address core and associated features of autism spectrum disorders (ASD) to enhance the success of elementary students with ASD in schools.
Specific Aims: The primary aim is to evaluate whether, compared to services as usual, MAAPS improves teacher outcomes and subsequent student educational outcomes. The investigators also intend to explore the feasibility and acceptability of MAAPS, costs associated with MAAPS, and analyze any potential modifiers of intervention effects and the implementation process.
Design: 60 schools will be randomized to either MAAPS or waitlist control. 120 teacher-student dyads will be enrolled from these 60 schools. Schools will be recruited from three sites: May Institute, University of South Florida, and University of Rochester. Student outcome measures assess overall school functioning, improvements in teacher-nominated target behaviors, core and associated features of ASD. Teacher outcome measures assess feasibility, acceptability, and usability of MAAPS and teacher implementation fidelity.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MAAPS
Modular intervention system integrating evidence-based strategies to address core and associated features of ASD and ongoing coaching.
MAAPS
Modular intervention system integrating evidence-based strategies to address core and associated features of ASD and ongoing coaching.
Waitlist control
Services as usual.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MAAPS
Modular intervention system integrating evidence-based strategies to address core and associated features of ASD and ongoing coaching.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Attending a public elementary school (K-6th grade)
* Attending school in person at least one day per week
* No planned changes in school placement or core team members in upcoming school year
* Parents/guardians able to participate in study-related activities (e.g., informed consent process and completion of study measures)
* Child's teacher consents to participate
Exclusion Criteria
* Motor disabilities such as cerebral palsy
* Genetic disorder known to be associated with ASD such as Fragile X, Down Syndrome, tuberous sclerosis
5 Years
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of South Florida
OTHER
University of Rochester
OTHER
May Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Cynthia Anderson
Senior Vice President of Applied Behavior Analysis and Director of the National Autism Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Cynthia Anderson, PhD, BCBA-D-D
Role: PRINCIPAL_INVESTIGATOR
May Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of South Florida
Tampa, Florida, United States
Kaitlin M Gould
Randolph, Massachusetts, United States
University of Rochester
Rochester, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R324A200154
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.